Luteolin as an Antioxidant & Anti-Inflammatory

This is the best-established part of luteolin's biology. In laboratory systems, luteolin is a strong direct antioxidant — its molecular shape lets it neutralize free radicals efficiently — and, more importantly, it activates the cell's own antioxidant defense system through the Nrf2 pathway while quieting the master inflammatory switch, NF-κB. Downstream, that translates into lower production of the inflammatory messengers (TNF-α, IL-6, IL-1β) and the inflammatory enzymes (iNOS, COX-2) that drive tissue damage. This page explains those mechanisms in plain language, keeps the important distinction between what a cell in a dish does and what a serving of celery does, and includes the pro-oxidant caveat that honest antioxidant science requires.

Table of Contents

  1. The Molecule: Why Luteolin's Shape Matters
  2. Direct Free-Radical Scavenging
  3. The Nrf2 Switch: Your Own Antioxidant Enzymes
  4. The NF-κB Switch: Turning Down Inflammation
  5. Cytokines: TNF-α, IL-6, and IL-1β
  6. iNOS, COX-2, and the Enzymes of Inflammation
  7. Metal Chelation and the Pro-Oxidant Caveat
  8. What This Means in a Real Diet
  9. Key Research Papers
  10. Connections
  11. Featured Videos

The Molecule: Why Luteolin's Shape Matters

Luteolin is a flavone with the chemical name 3',4',5,7-tetrahydroxyflavone. That mouthful describes four hydroxyl (–OH) groups hung on a flavone skeleton, and their arrangement is what makes luteolin a good antioxidant. Three features do the heavy lifting:

In short, luteolin is built to absorb a chemical “hit” and stay stable afterward, which is exactly what an antioxidant needs to do. The reviews by López-Lázaro (2009) and Seelinger and colleagues (2008) lay out this structure–activity relationship in detail.

Back to Table of Contents

Direct Free-Radical Scavenging

The simplest antioxidant action is direct scavenging: the molecule meets a reactive oxygen or nitrogen species — a superoxide radical, a hydroxyl radical, peroxynitrite — and donates a hydrogen atom to neutralize it before it can damage DNA, lipids, or proteins. In test-tube assays, luteolin is among the more potent flavonoid scavengers, consistently outperforming flavonoids that lack its catechol B-ring.

It is important to be realistic about how much of luteolin's real-world benefit comes from this direct scavenging. The concentrations that produce strong scavenging in a cuvette are higher than what circulates in blood after eating luteolin-rich foods, because luteolin is poorly absorbed and rapidly metabolized (see the Sources page). This is why most researchers now believe the more meaningful antioxidant effect at achievable doses is indirect — luteolin acting as a signal that switches on the body's own, far larger, enzymatic antioxidant machinery, which is the subject of the next section.

Back to Table of Contents

The Nrf2 Switch: Your Own Antioxidant Enzymes

The body does not rely on dietary antioxidants to do its heavy lifting. It has its own enzymatic defense — heme oxygenase-1 (HO-1), glutathione, glutathione peroxidase, superoxide dismutase, and others — that is far more powerful than any single molecule from food. The genes for these enzymes are controlled by a transcription factor called Nrf2, which normally sits leashed in the cell by a partner protein, Keap1. When Nrf2 is released, it travels to the nucleus and switches on the whole antioxidant enzyme program.

Luteolin activates Nrf2. Studies such as Tan and colleagues (2019) show luteolin modulating the p62/Keap1/Nrf2 axis to release Nrf2, raising HO-1 and related protective enzymes and reducing oxidative injury in disease models. This matters because an Nrf2-driven effect is catalytic and self-renewing: a small amount of luteolin can trigger the production of enzymes that then neutralize radicals over and over, whereas a directly-scavenging molecule is used up after a single encounter. This is the likely explanation for how luteolin can have meaningful antioxidant effects at the modest concentrations achievable from food.

Back to Table of Contents

The NF-κB Switch: Turning Down Inflammation

If Nrf2 is the “defense on” switch, NF-κB is the “inflammation on” switch. NF-κB is a transcription factor that, when activated, turns on the genes for a broad set of inflammatory products — cytokines, chemokines, adhesion molecules, and inflammatory enzymes. Chronic inappropriate NF-κB activation underlies much low-grade inflammation.

Luteolin is a well-documented NF-κB inhibitor. In one of the foundational mechanistic papers, Xagorari and colleagues (2001) showed that luteolin blocked an endotoxin-stimulated phosphorylation cascade in macrophages, preventing the downstream production of proinflammatory cytokines. Because so many inflammatory outputs funnel through NF-κB, inhibiting it at the top of the cascade is a leveraged way to reduce inflammation across many products at once. This single mechanism is the common thread linking luteolin's effects in macrophages, in brain microglia (see Brain & Neuroinflammation), and in the airway.

Back to Table of Contents

Cytokines: TNF-α, IL-6, and IL-1β

Cytokines are the chemical messengers that immune cells use to coordinate inflammation. Three of the most important — tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) — are the messengers most consistently reduced by luteolin in laboratory studies, largely because they are downstream of the NF-κB switch it inhibits.

The review by Aziz and colleagues (2018) surveys the in vitro, in vivo, and computational evidence and finds a consistent pattern: across macrophages, epithelial cells, and animal models of inflammation, luteolin lowers these key cytokines. The practical significance is that TNF-α and IL-6 are the same messengers targeted by some of the most successful anti-inflammatory drugs in medicine, so a food molecule that nudges them downward is mechanistically interesting — while being, at food doses, far gentler and far weaker than a pharmaceutical, which is both its limitation and part of its safety.

Back to Table of Contents

iNOS, COX-2, and the Enzymes of Inflammation

Two inducible enzymes turn inflammatory signals into tissue-level effects:

Both enzymes are NF-κB target genes, so luteolin's inhibition of NF-κB reduces their induction. In macrophage models and animal studies of inflammation, luteolin lowers iNOS and COX-2 expression and the nitric oxide and prostaglandins they produce. This connects the molecular story to something tangible: less prostaglandin means less of the pain-and-swelling cascade, and less iNOS-driven nitric oxide means less oxidative and nitrosative stress in inflamed tissue. Peng and colleagues (2024) is one recent example examining luteolin's combined effect on oxidative stress and inflammatory signaling in a human cell line.

Back to Table of Contents

Metal Chelation and the Pro-Oxidant Caveat

Luteolin can bind (chelate) transition metals such as iron and copper. This is usually protective, because free iron and copper catalyze the Fenton reaction that generates the extremely damaging hydroxyl radical; by tying up these metals, luteolin removes a source of radical generation.

But intellectual honesty requires the flip side. Flavonoids, luteolin included, can under some conditions act as pro-oxidants rather than antioxidants — particularly at high concentrations, in the presence of free transition metals, or in certain cellular environments. The same catechol group that makes luteolin a good radical scavenger can, when it forms a quinone after oxidation, generate reactive species of its own. This context-dependent behavior is well recognized in flavonoid research and is one reason to be cautious about the assumption that “more antioxidant is always better.” It is also part of why isolated high-dose antioxidant supplements have sometimes disappointed or backfired in large human trials, while antioxidant-rich whole diets perform well. For luteolin, food-level intake is comfortably on the antioxidant side of this balance.

Back to Table of Contents

What This Means in a Real Diet

For the practical side — which foods, how much, and the absorption problem — see the Dietary Sources page.

Back to Table of Contents

Key Research Papers

  1. Xagorari A et al. (2001). Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. Journal of Pharmacology and Experimental Therapeutics. — PubMed 11123379
  2. Aziz N et al. (2018). Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. Journal of Ethnopharmacology. — PubMed 29801717
  3. Seelinger G et al. (2008). Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Medica. — PubMed 18937165
  4. López-Lázaro M (2009). Distribution and biological activities of the flavonoid luteolin. Mini-Reviews in Medicinal Chemistry. — PubMed 19149659
  5. Lin Y et al. (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Current Cancer Drug Targets. — PubMed 18991571
  6. Tan X et al. (2019). Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway. Frontiers in Pharmacology. — PubMed 32038239
  7. Tsai KJ et al. (2021). Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway. Molecules. — PubMed 34770867
  8. Tossetta G et al. (2022). Natural and synthetic compounds in Ovarian Cancer: A focus on the NRF2/KEAP1 pathway. Pharmacological Research. — PubMed 35901941
  9. Peng Z et al. (2024). Effect of luteolin on oxidative stress and inflammation in a human osteoblast cell line. BMC Pharmacology and Toxicology. — PubMed 38997762
  10. Shi M et al. (2024). Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics. Phytotherapy Research. — PubMed 38088265

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents